Multiple structural brain measures obtained by three-dimensional magnetic resonance imaging to distinguish between schizophrenia patients and normal subjects

Schizophrenia Bulletin

Volumn 30, Issue 2, 2004, Pages 393-404

  Nakamura, Kazue ^b   Kawasaki, Yasuhiro ^b   Suzuki, Michio ^b   Hagino, Hirofumi ^b   Kurokawa, Kenzo ^b   Takahashi, Tsutomu ^b   Niu, Lisha ^b   Matsui, Mie ^b   Seto, Hikaru ^b   Kurachi, Masayoshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Department of Neuropsychiatry ^*

Author keywords

Diagnosis; Discriminant function analysis; Magnetic resonance imaging; Schizophrenia

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADOLESCENT; ADULT; ARTICLE; BRAIN; BRAIN LATERAL VENTRICLE; BRAIN THIRD VENTRICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; THREE DIMENSIONAL IMAGING;

EID: 3042617496     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a007087     Document Type: Article

References (54)

1. Alpert, N.M.; Berdichevsky, D.; Levin, Z.; Morris, E.D.; and Fischman, A.J. Improved methods for image registration. NeuroImage, 3:10-18, 1996.
2. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry, 154(Suppl 4):1-63, 1997.
3. Arango, C.; Bartko, J.J.; Gold, J.M.; and Buchanan, R.W. Prediction of neuropsychological performance by neurological signs in schizophrenia. American Journal of Psychiatry, 156:1349-1357, 1999.
4. Aso, M.; Suzuki, M.; Kawasaki, Y.; Matsui, M.; Hagino, H.; Kurokawa, K.; Seto, H.; and Kurachi, M. Sylvian fissure and medial temporal lobe structures in patients with schizophrenia: A magnetic resonance imaging study. Psychiatry and Clinical Neurosciences, 55:49-56, 2001.
5. Baaré, W.F.C.; Hulshoff Pol, H.E.; Hijman, R.; Mari, W.P. Th.; Viergever, M.A.; and Kahn, R.S. Volumetric analysis of frontal lobe regions in schizophrenia: Relation to cognitive function and symptomatology. Biological Psychiatry, 45:1597-1605, 1999.
6. Barta, P.E.; Pearlson, G.D.; Powers, R.E.; Richards, S.S.; and Tune, L.E. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. American Journal of Psychiatry, 147:1457-1462, 1990.
7. Bogerts, B.; Lieberman, J.A.; Ashtari, M.; Bilder, R.M.; Degreef, G.; Lerner, G.; Johns, C.; and Masiar, S. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biological Psychiatry, 33:236-246, 1993.
8. Bryant, N.L.; Buchanan, R.W.; Vladar, K.; Breier, A.; and Rothman, M. Gender differences in temporal lobe structures of patients with schizophrenia: A volumetric MRI study. American Journal of Psychiatry, 156:603-609, 1999.
9. Buchanan, R.W.; Vladar, K.; Barta, P.E.; and Perlson, G.D. Structural evaluation of the prefrontal cortex in schizophrenia. American Journal of Psychiatry, 155:1049-1055, 1998.
10. Campana, A.; Duci, A.; Gambini, O.; and Scarone, S. An artificial neural network that uses eye-tracking performance to identify patients with schizophrenia. Schizophrenia Bulletin, 25(4):789-799, 1999.
11. Carter, J.W.; Parnas, J.; Cannon, T.D.; Schulsinger, F.; and Mednick, S.A. MMPI variables predictive of schizophrenia in the Copenhagen high-risk project: A 25-year follow-up. Acta Psychiatrica Scandinavica, 99:432-440, 1999.
12. Crow, T.J.; MacMillian, J.F.; Johnson, A.L.; and Johnstone, E.C. A randomized controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148:120-127, 1986.
13. Cummings, J.L. Frontal-subcortical circuits and human behavior. Archives of Neurology, 50:873-880, 1993.
14. Daniel, D.G.; Goldberg, T.E.; Gibbons, R.D.; and Weinberger, D.R. Lack of a bimodal distribution of ventricular size in schizophrenia: A Gaussian mixture analysis of 1056 cases and controls. Biological Psychiatry, 30:887-903, 1991.
15. Degreef, G.; Ashtari, M.; Bogerts, B.; Bilder, R.M.; Jody, D.N.; Alvir, J.M.J.; and Lieberman, J.A. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Archives of General Psychiatry, 49:531-537, 1992.
16. DeLisi, L.E.; Hoff, A.L.; Kushner, M.; Calev, A.; and Stritzke, P. Left ventricular enlargement associated with diagnostic outcome of schizophreniform disorder. Biological Psychiatry, 32:199-201, 1992.
17. Evans, J.D.; Heaton, R.K.; Paulsen, J.S.; McAdams, L.A.; Heaton, S.C.; and Jeste, D.V. Schizoaffective disorder: A form of schizophrenia or affective disorder? Journal of Clinical Psychiatry, 60:874-882, 1999.
18. Fukuzako, H.; Fukuzako, T.; Hashiguchi, T.; Hokazono, Y.; Takeuchi, K.; Hirakawa, K.; Ueyama, K.; Takigawa, M.; Kajiya, Y.; Nakajo, M.; and Fujimoto, T. Reduction in hippocampal formation volume is caused mainly by its shortening in chronic schizophrenia: Assessment by MRI. Biological Psychiatry, 39:938-945, 1996.
19. Goldstein, G.; Allen, D.N.; and Weiner, C.L. Lateralized brain dysfunction in schizophrenia: A comparison with patients with lateralized structural lesions. Schizophrenia Research, 40:179-187, 1999.
20. Gur, R.E.; Turetsky, B.I.; Bilker, W.B.; and Gur, R.C. Reduced gray matter volume in schizophrenia. Archives of General Psychiatry, 56:905-911, 1999.
21. Kawasaki, Y.; Maeda, Y.; Urata, K.; Higashima, M.; Yamaguchi, N.; Suzuki, M.; Takashima, T.; and Ide, Y. A quantitative magnetic resonance imaging study of patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 242:268-272, 1993.
22. Knott, V.; Mahoney, C.; Labelle, A.; Ripley, C.; Cavazzoni, P.; and Jones, B. Event-related potentials in schizophrenic patients during a degraded stimulus version of the visual continuous performance task. Schizophrenia Research, 35:263-278, 1999.
23. Kurokawa, K.; Nakamura, K.; Sumiyoshi, T.; Hagino, H.; Yotsutsuji, T.; Yamashita, I.; Suzuki, M.; Matsui, M.; and Kurachi, M. Ventricular enlargement in schizophrenia spectrum patients with prodromal symptoms of obsessive-compulsive disorder. Psychiatry Research, 99:83-91, 2000.
24. Kwon, J.S.; McCarley, R.W.; Hirayasu, Y.; Anderson, J.E.; Fischer, I.A.; Kikinis, R.; Jolesz, F.A.; and Shenton, M.E. Left planum temporale volume reduction in schizophrenia. Archives of General Psychiatry, 56:142-148, 1999.
25. Lawrie, S.M., and Abukmeil, S.S. Brain abnormality in schizophrenia. British Journal of Psychiatry, 172:110-120, 1998.
26. Leonard, C.M.; Kuldau, J.M.; Breier, J.I.; Zuffante, P.A.; Gautier, E.R.; Heron, D.C.; Lavery, E.M.; Packing, J.; Williams, S.A.; and DeBose, C.A. Cumulative effect of anatomical risk factor for schizophrenia: An MRI study. Biological Psychiatry, 46:374-382, 1999.
27. Levy, A.V.; Gomez-Mont, F.; Volkow, N.D.; Corona, J.F.; Brodie, J.D.; and Cancro, R. Spatial low frequency pattern analysis in positron emission tomography: A study between normals and schizophrenics. Journal of Nuclear Medicine, 33:287-295, 1991.
28. Liddle, P.F.; Friston, K.J.; Frith, C.D.; and Frackowiak, R.S.J. Cerebral blood flow and mental processes in schizophrenia. Journal of the Royal Society of Medicine, 85:224-227, 1992.
29. Loebel, A.D.; Lieberman, J.A.; Alvir, J.M.J.; Mayerhoff, D.I.; Geisler, S.H.; and Szymanski, S.R. Duration of psychosis and outcome in first-episode schizophrenia. American Journal of Psychiatry, 149:1183-1188, 1992.
30. Mathalon, D.H.; Sullivan, E.V.; Rawles, J.M.; and Pfefferbaum, A. Correction for head size in brain-imaging measurements. Psychiatry Research, 50:121-139, 1993.
31. McCarley, R.W.; Wible, C.G.; Frumin, M.; Hirayasu, Y.; Levitt, J.J.; Fischer, I.A.; and Shenton, M.E. MRI anatomy of schizophrenia. Biological Psychiatry, 45:1099-1119, 1999.
32. New Japanese MMPI Committee. Study of Standardization for the New Japanese MMPI. Kyoto, Japan: San-Kyo-Bo, 1997.
33. Nohara, S.; Suzuki, M.; Kurachi, M.; Yamashita, I.; Matsui, M.; Seto, H.; and Saitoh, O. Neural correlates of memory organization deficits in schizophrenia: A single photon emission computed tomography study with 99m Tc-ethyl-cysteinate dimmer during a verbal learning task. Schizophrenia Research, 42:209-222, 2000.
34. Pakes, G.E. Dosage and administration: Haloperidol decanoate and the treatment of chronic schizophrenia, Vol. 2. In: Johnson, D.A.W., ed. Therapeutics Today Series. Auckland, New Zealand: ADIS Press, 1982.
35. Pearlson, G.D.; Barta, P.E.; Powers, R.E.; Menon, R.R.; Richards, S.S.; Aylward, E.H.; Federman, E.B.; Chase, G.A.; Petty, R.G.; and Tien, A.Y. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biological Psychiatry, 41:1-14, 1997.
36. Pfefferbaum, A.; Sullivan, E.V.; Rosenbloom, M.J.; Shear, P.K.; Mathalon, D.H.; and Lim, K.O. Increase in brain cerebrospinal fluid volume is greater in older than younger alcoholic patients: A replication study and CT/MRI comparison. Psychiatry Research, 50:257-274, 1993.
37. Sanfilipo, M.; Lafargue, T.; Arena, L.; Rusinek, H.; Kushner, K.; Lautin, A.; Loneragan, C.; Vaid, G.; Rotrosen, J.; and Wolkin, A. Fine volumetric analysis of the cerebral ventricular system in schizophrenia: Further evidence for multifocal mild to moderate enlargement. Schizophrenia Bulletin, 26(1):201-216, 2000a.
38. Sanfilipo, M.; Lafargue, T.; Rusinek, H.; Arena, L.; Loneragan, C.; Lautin, A.; Feiner, D.; Rotrosen, J.; and Wolkin, A. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: Relationship to negative symptoms. Archives of General Psychiatry, 57:471-480, 2000b.
39. Schwartz, J.M.; Aylward, E.; Barta, P.E.; Tune, L.E.; and Pearlson, G.D. Sylvian fissure sizes in schizophrenia measured with the magnetic resonance imaging rating protocol of the consortium to establish a registry for Alzheimer's disease. American Journal of Psychiatry, 149:1195-1198, 1992.
40. Shenton, M.E.; Kikinis, R.; Jolesz, F.A.; Pollak, S.D.; LeMay, M.; Wible, C.G.; Hokama, H.; Martin, J.; Metcalf, D.; Coleman, M.; and McCarley, R.W. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study. New England Journal of Medicine, 327:604-612, 1992.
41. Strakowski, S.M.; DelBello, M.P.; Sax, K.W.; Zimmerman, M.E.; Shear, P.K.; Hawkins, J.M.; and Larson, E.R. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Archives of General Psychiatry, 56:254-260, 1999.
42. Suddath, R.L.; Christison, G.W.; Torrey, E.F.; Casanova, M.F.; and Weinberger, D.R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine, 322:789-794, 1990.
43. Sullivan, E.V.; Deshmukh, A.; Desmond, J.E.; Mathalon, D.H.; Rosenbloom, M.J.; Lim, K.O.; and Pfefferbaum, A. Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia. Archives of General Psychiatry, 57:894-902, 2000.
44. Suzuki, M.; Nohara, S.; Hagino, H.; Kurokawa, K.; Yotsutsuji, T.; Kawasaki, Y.; Takahashi, T.; Matsui, M.; Watanabe, N.; Seto, H.; and Kurachi, M. Regional change in gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophrenia Research, 55:41-54, 2002.
45. Uchino, J.; Nakane, Y.; and Ohta, Y. Brain X-ray CT image. Schizophrenia. Clinical Psychiatry, 17:729-735, 1988. [In Japanese].
46. Vita, A.; Dieci, M.; Silenzi, C.; Tenconi, F.; Giobbio, G.M.; and Invemizzi, G. Cerebral ventricular enlargement as a generalized feature of schizophrenia: A distribution analysis on 502 subjects. Schizophrenia Research, 44:25-34, 2000.
47. Vita, A.; Giobbio, G.M.; Garbarini, M.; Morganti, C.; and Dieci, M. Prognostic value of ventricular enlargement in acute schizophreniform disorder. [Letter]. Lancet, 338:1458, 1991.
48. Ward, K.E.; Friedman, L.; Wise, A.; and Schulz, S.C. Meta-analysis of brain and cranial size in schizophrenia. Schizophrenia Research, 22:197-213, 1996.
49. Whitworth, A.B.; Honeder, M.; Kremser, C.; Kemmler, G.; Felber, S.; Hausmann, A.; Wanko, C.; Wechdorn, H.; Aichner, F.; Stuppaeck, C.H.; and Fleischhacker, W.W. Hippocampal volume reduction in male schizophrenic patients. Schizophrenia Research, 31:73-81, 1998.
50. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. Geneva, Switzerland: WHO, 1993.
51. Wright, I.C.; McGuire, P.K.; Poline, J.B.; Travere, J.M.; Murray, R.M.; Frith, C.D.; Frackowiak, R.S.; and Friston, K.J. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neurolmage, 2:244-252, 1995.
52. Wright, I.C.; Rabe-Hesketh, S.; Woodruff, P.W.R.; David, A.S.; Murray, R.M.; and Bullmore, E.T. Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry, 157:16-25, 2000.
53. Wyatt, R.J. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia. Schizophrenia Research, 5:201-202, 1991.
54. Zipursky, R.B.; Lim, K.O.; Sullivan, E.V.; Brown, B.W.; and Pfefferbaum, A. Widespread cerebral gray matter volume deficits in schizophrenia. Archives of General Psychiatry, 49:195-205, 1992.